Back to Treatments

Treatment

Clofazimine (as part of an optimized background regimen for MDR-TB)

1
Conditions
40
Trials
7,000
Participants
70%
Average Safety

Condition Evidence

HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance

40 trials · 7,000 participants

70% effectiveness · 70% safety
Clofazimine (as part of an optimized background regimen for MDR-TB) | DFDA